Risk factors for aquiring multidrug-resistant organisms in urinary tract infections: A systematic literature review

Saudi Pharmaceutical Journal

Volumn 26, Issue 5, 2018, Pages 678-684

  Tenney, Justin ^a   Hudson, Nicholas ^b   Alnifaidy, Hazar ^c   Li, Justin Ting Cheung ^a   Fung, Kathy Harriet ^a  

^a Prince of Wales Hospital   (Hong Kong)

^b is an assistant professor of nursing at Bethel College   (United States)

^c SIDRA MEDICAL AND RESEARCH CENTER   (Qatar)

Author keywords

Cystitis; Microbial drug resistance; Pyelonephritis; Risk factors; Systematic review; Urinary tract infection

Indexed keywords

ANTIBIOTIC RESISTANCE; BLADDER CATHETERIZATION; DATA EXTRACTION; ETHNIC GROUP; HUMAN; MULTIDRUG RESISTANCE; NURSING HOME; QUALITY CONTROL; REVIEW; RISK FACTOR; TRAVEL; URINARY TRACT INFECTION;

EID: 85042049165     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsps.2018.02.023     Document Type: Review

References (35)

1. Allen, U.D., MacDonald, N., Fuite, L., Chan, F., Stephens, D., Risk factors for resistance to “first-line” antimicrobials among urinary tract isolates of Escherichia coli in children. CMAJ 160:10 (1999), 1436–1440.
2. Anthony, J.S., 2002. Infections of the urinary tract. Campbell's Urology, eighth ed. pp. 515–602.
3. Arslan, H., Azap, O.K., Ergonul, O., Timurkaynak, F., Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. J. Antimicrob. Chemother. 56 (2005), 914–918.
4. Brown, P.D., Freeman, A., Foxman, B., Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan. Clin. Infect. Dis. 34 (2002), 1061–1066.
5. Burman, W.J., Breese, P.E., Murray, B.E., Singh, K.V., Batal, H.A., MacKenzie, T.D., et al. Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates. Am. J. Med. 115 (2003), 358–364.
6. Colgan, R., Johnson, J.R., Kuskowski, M., Gupta, K., Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis. Antimicrob. Agents Chemother. 52 (2008), 846–851.
7. Colodner, R., Rock, W., Chazan, B., Keller, N., Guy, N., Sakran, W., et al. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur. J. Clin. Microbiol. Infect. Dis. Official Publ. Eur. Soc. Clin. Microbiol. 23:3 (2004), 163–167.
8. Ena, J., Amador, C., Martínez, C., Ortiz de la Tabla, V., Risk factors for acquisition of urinary tract infections caused by ciprofloxacin-resistant Escherichia coli. J. Urol. 153 (1995), 117–120.
9. Eshetie, S., Unakal, C., Gelaw, A., Ayelign, B., Endris, M., Moges, F., Multidrug resistant and carbapenemase producing Enterobacteriaceae among patients with urinary tract infection at referral Hospital, Northwest Ethiopia. Antimicrob. Resist. Infect. Control., 17(4), 2015, 12.
10. Faine, B.A., Harland, K.K., Porter, B., Liang, S.Y., Mohr, N., A clinical decision rule identifies risk factors associated with antimicrobial-resistant urinary pathogens in the emergency departmenta retrospective validation study. Ann. Pharmacother. 49:6 (2015), 649–655.
11. Gangcuangco, L.M., Alejandria, M., Henson, K.E., Alfaraz, L., Ata, R.M., Lopez, M., et al. Prevalence and risk factors for trimethoprim-sulfamethoxazole-resistant Escherichia coli among women with acute uncomplicated urinary tract infection in a developing country. Int. J. Infect. Dis. 34 (2015), 55–60.
12. Gould, C.V., Umscheid, C.A., Agarwal, R.K., Kuntz, G., Pegues, D.A., Guideline for prevention of catheter-associated urinary tract infections. Infect. Control Hospital Epidemiol. 31 (2010), 319–326.
13. Gupta, K., Hooton, M.H., Naber, K.G., Wullt, B., Colgan, R., Miller, L.G., et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women a 2010 update by the infectious diseases society of America and the european society for microbiology and infectious diseases. Clin. Infect. Dis. 52:5 (2011), e103–e120, 10.1093/cid/ciq257.
14. Hertz, F.B., Schønning, K., Rasmussen, S.C., Littauer, P., Knudsen, J.D., Løbner-Olesen, A., et al. 2016. Epidemiological factors associated with ESBL- and non ESBL-producing E. coli causing urinary tract infection in general practice. Infect. Dis. (Lond). 48(3) 241–245.
15. Ho, P.L., Wong, R.C., Yip, K.S., Loke, S.L., Leung, M.S., Mak, G.C., et al. Antimicrobial resistance in Escherichia coli outpatient urinary isolates from women emerging multidrug resistance phenotypes. Diagn. Microbiol. Infect. Dis. 59 (2007), 439–445.
16. Hooton, T.M., Bradley, S.F., Cardenas, D.D., Colgan, R., Geerlings, S.E., Rice, J.C., et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults 2009 international clinical practice guidelines from the infectious diseases society of America. Clin. Infect. Dis. 50:5 (2010), 625–663, 10.1086/650482.
17. Ikram, R., Psutka, R., Carter, A., Priest, P., An outbreak of multidrug resistant Escherichia coli urinary tract infection in an elderly population a case-control study of risk factors. BMC Infect. Dis., 9, 2015, 224.
18. Jadoon, R.J., Jalal-ud-Din, M., Khan, S.A., E. coli resistance to ciprofloxacin and common associated factors. J. Colloids Phys. Surg. Pak. 25:11 (2015), 824–827.
19. Johnson, L., Sabel, A., Burman, W.J., Everhart, R.M., Rome, M., MacKenzie, T.D., et al. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. Am. J. Med. 121 (2008), 876–884.
20. Kalil, A.C., Metersky, M.L., Klompas, M., Muscedere, J., Sweeney, D.A., Palmer, L.B., et al. Management of adults with hospital-acquired and ventilator-associated pneumonia 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society. Clin. Infect. Dis., 63, 2016, e61.
21. Kang, M.S., Lee, B.S., Lee, H.J., Hwang, S.W., Han, Z.A., Prevalence of and risk factors for multidrug-resistant bacteria in urine cultures of spinal cord injury patients. Ann. Rehabil. Med. 39:5 (2015), 686–695.
22. Khawcharoenporn, T., Vasoo, S., Singh, K., 2013. Urinary tract infections due to multidrug-resistant enterobacteriaceae prevalence and risk factors in a chicago emergency department. Emergency Medicine International, vol. 2013, Article ID 258517.
23. Killgore, K.M., March, K.L., Guglielmo, B.J., Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection. Ann. Pharmacother. 38:7–8 (2004), 1148–1152.
24. Klevens R.M., Edwards, J.R., Richards, Jr. C.L., Horan, T.C., Gaynes, R.P., Pollock, D.A., et al., 2002. Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, Public Health Rep. 2007 Mar-Apr 122(2). pp. 160–166.
25. Lee, G., Cho, Y.H., Shim, B.S., Lee, S.D., Risk factors for antimicrobial resistance among the Escherichia coli strains isolated from Korean patients with acute uncomplicated cystitis a prospective and nationwide study. J. Korean Med. Sci. 25 (2010), 1205–1209.
26. Magill, S.S., Edwards, J.R., Bamberg, W., Beldavs, Z.G., Dumyati, G., Kainer, M.A., et al. Multistate point-prevalence survey of health care-associated infections, 2011. New England J. Med. 370 (2014), 1198–1208.
27. Magiorakos, A.P., Srinivasan, A., Carey, R.B., Carmeli, Y., Falagas, M.E., Giske, C.G., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18 (2012), 268–281.
28. Metlay, J.P., Strom, B.L., Asch, D.A., Prior antimicrobial drug exposure a risk factor for trimethoprim-sulfamethoxazole-resistant urinary tract infections. J. Antimicrob. Chemother. 51:4 (2003), 963–970 Epub 2003 Feb 25.
29. O'Connell, D., The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Appl. Eng. Agric. 18 (2002), 585–590.
30. Osthoff, M., Mcguinness, S.L., Wagen, A.Z., Eisen, D.P., 2015. Urinary tract infections due to extended-spectrum beta lactamase-producing gram-negative bacteria identification of risk factors and outcome predictors in an Australian tertiary-referral hospital. Int. J. Infect. Dis. pii S1201-9712(15)00067-3.
31. Shaikh, S., Fatima, J., Shakil, S., Rizvi, S.M.D., Kamal, M.A., Antibiotic resistance and extended spectrum beta-lactamasestypes, epidemiology and treatment. Saudi J. Biol. Sci. 22:1 (2015), 90–101.
32. Talan, D.A., Krishnadasan, A., Abrahamian, F.M., Stamm, W.E., Moran, G.J., Group EMINS. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis. Clin. Infect. Dis. 47 (2008), 1150–1158.
33. Toner, L., Papa, N., Aliyu, S.H., Dev, H., Lawrentschuk, N., Al-Hayek, S., Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections incidence and antibiotic susceptibility profile over 9 years. World J. Urol., 2015.
34. Wright, S.W., Wrenn, K.D., Haynes, M.L., Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates. J. Gen. Int. Med. 14:10 (1999), 606–609.
35. Yoon, S.B., Prevalence and risk factors for highly resistant microorganisms in urinary isolates from newly admitted patients in the National Rehabilitation Center, Korea. J. Rehabil. Med. 46:8 (2014), 814–818.